Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 USD | +1.10% | +2.60% | +14.68% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.68% | 1.68B | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Oppenheimer Raises Soleno Therapeutics Price Target to $14 Form $8, Maintains Outperform Rating